HepaRegenix GmbH
Management
Linda Greenbaum
Chief Medical Officer
Dr. Linda Greenbaum is a hepatologist with 10 years of experience in both early and late stage clinical development. She recently served as executive director in the Biomedical Research division of Novartis, where she supported early stage liver disease development and strategy . Linda joined HepaRegeniX in early 2024 as Chief Medical Officer and is leading development of our clinical programs. Linda received her medical degree from the Columbia University Vagelos College of Physicians and Surgeons and Gastroenterology and Hepatology fellowship training at the University of Pennsylvania. She served on the faculty of the University of Pennsylvania and Thomas Jefferson University college of Medicine where she combined clinical care with research programs in liver regeneration and liver stem cel biology.